Balchem Cost Of Revenue vs Ebit Per Revenue Analysis

BCPC Stock

USD 182.44 2.13 1.18%

Balchem financial indicator trend analysis is way more than just evaluating Balchem prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Balchem is a good investment. Please check the relationship between Balchem Cost Of Revenue and its Ebit Per Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.

Cost Of Revenue vs Ebit Per Revenue

Cost Of Revenue vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Balchem Cost Of Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Balchem's Cost Of Revenue and Ebit Per Revenue is 0.13. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of Balchem, assuming nothing else is changed. The correlation between historical values of Balchem's Cost Of Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Balchem are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Cost Of Revenue i.e., Balchem's Cost Of Revenue and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

0.13

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Balchem income statement and represents the costs associated with goods and services Balchem provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Ebit Per Revenue

Most indicators from Balchem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Balchem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.At present, Balchem's Enterprise Value Over EBITDA is projected to increase based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 24.58, whereas Tax Provision is forecasted to decline to about 24.2 M.

	2021	2022	2023	2024 (projected)
Gross Profit	243.2M	280.5M	302.1M	317.2M
Total Revenue	799.0M	942.4M	922.4M	968.6M

Gross Profit Total Revenue

Balchem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Cash	Cash And Short Term Investments	Non Currrent Assets Other	Accounts Payable	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.84	0.9	0.96	0.97	0.99	0.77	0.96	0.99	0.97	0.62	0.88	0.98	0.18	0.84	0.92	0.91	0.78	-0.24	-0.28	-0.28	-0.23	0.92	0.93	0.52	0.48
Short Long Term Debt Total	0.84		0.66	0.81	0.68	0.78	0.97	0.67	0.87	0.75	0.47	0.99	0.78	0.31	0.64	0.98	0.69	0.46	0.06	-0.47	-0.47	-0.32	0.68	0.98	0.4	0.38
Other Current Liab	0.9	0.66		0.94	0.9	0.91	0.6	0.9	0.88	0.93	0.61	0.7	0.89	0.0	0.8	0.77	0.82	0.74	-0.23	-0.23	-0.23	-0.24	0.87	0.78	0.5	0.48
Total Current Liabilities	0.96	0.81	0.94		0.93	0.95	0.74	0.92	0.96	0.96	0.62	0.83	0.95	0.22	0.81	0.89	0.88	0.75	-0.15	-0.29	-0.29	-0.21	0.94	0.89	0.52	0.49
Total Stockholder Equity	0.97	0.68	0.9	0.93		0.98	0.6	1.0	0.94	0.97	0.63	0.73	0.97	0.09	0.85	0.8	0.93	0.85	-0.35	-0.17	-0.17	-0.17	0.92	0.81	0.52	0.48
Property Plant And Equipment Net	0.99	0.78	0.91	0.95	0.98		0.72	0.97	0.98	0.98	0.62	0.83	0.98	0.14	0.87	0.88	0.91	0.77	-0.31	-0.29	-0.29	-0.23	0.92	0.88	0.5	0.47
Net Debt	0.77	0.97	0.6	0.74	0.6	0.72		0.59	0.83	0.67	0.31	0.95	0.71	0.33	0.57	0.93	0.64	0.27	-0.02	-0.68	-0.68	-0.37	0.61	0.94	0.23	0.2
Retained Earnings	0.96	0.67	0.9	0.92	1.0	0.97	0.59		0.94	0.96	0.58	0.73	0.98	0.07	0.8	0.79	0.94	0.85	-0.38	-0.16	-0.16	-0.15	0.94	0.8	0.48	0.44
Non Current Assets Total	0.99	0.87	0.88	0.96	0.94	0.98	0.83	0.94		0.96	0.56	0.91	0.97	0.2	0.83	0.94	0.91	0.7	-0.25	-0.39	-0.39	-0.26	0.9	0.95	0.46	0.42
Net Receivables	0.97	0.75	0.93	0.96	0.97	0.98	0.67	0.96	0.96		0.69	0.79	0.98	0.18	0.87	0.85	0.87	0.82	-0.26	-0.23	-0.23	-0.27	0.95	0.86	0.58	0.55
Common Stock Shares Outstanding	0.62	0.47	0.61	0.62	0.63	0.62	0.31	0.58	0.56	0.69		0.49	0.59	0.18	0.8	0.54	0.41	0.75	0.16	0.27	0.27	-0.17	0.54	0.55	0.97	0.98
Non Current Liabilities Total	0.88	0.99	0.7	0.83	0.73	0.83	0.95	0.73	0.91	0.79	0.49		0.83	0.29	0.67	0.99	0.72	0.52	-0.02	-0.45	-0.45	-0.32	0.73	0.98	0.41	0.39
Inventory	0.98	0.78	0.89	0.95	0.97	0.98	0.71	0.98	0.97	0.98	0.59	0.83		0.13	0.8	0.88	0.9	0.81	-0.33	-0.25	-0.25	-0.25	0.96	0.87	0.48	0.45
Other Current Assets	0.18	0.31	0.0	0.22	0.09	0.14	0.33	0.07	0.2	0.18	0.18	0.29	0.13		0.24	0.28	0.09	-0.01	0.27	-0.27	-0.27	0.02	0.18	0.29	0.16	0.16
Other Stockholder Equity	0.84	0.64	0.8	0.81	0.85	0.87	0.57	0.8	0.83	0.87	0.8	0.67	0.8	0.24		0.72	0.69	0.68	-0.11	-0.19	-0.19	-0.28	0.71	0.75	0.68	0.68
Total Liab	0.92	0.98	0.77	0.89	0.8	0.88	0.93	0.79	0.94	0.85	0.54	0.99	0.88	0.28	0.72		0.78	0.59	-0.05	-0.43	-0.43	-0.3	0.8	0.99	0.45	0.43
Property Plant And Equipment Gross	0.91	0.69	0.82	0.88	0.93	0.91	0.64	0.94	0.91	0.87	0.41	0.72	0.9	0.09	0.69	0.78		0.71	-0.31	-0.28	-0.28	-0.04	0.87	0.8	0.34	0.27
Total Current Assets	0.78	0.46	0.74	0.75	0.85	0.77	0.27	0.85	0.7	0.82	0.75	0.52	0.81	-0.01	0.68	0.59	0.71		-0.12	0.36	0.36	-0.03	0.8	0.57	0.7	0.68
Short Term Debt	-0.24	0.06	-0.23	-0.15	-0.35	-0.31	-0.02	-0.38	-0.25	-0.26	0.16	-0.02	-0.33	0.27	-0.11	-0.05	-0.31	-0.12		0.28	0.28	0.09	-0.32	-0.04	0.23	0.26
Cash	-0.28	-0.47	-0.23	-0.29	-0.17	-0.29	-0.68	-0.16	-0.39	-0.23	0.27	-0.45	-0.25	-0.27	-0.19	-0.43	-0.28	0.36	0.28		1.0	0.33	-0.21	-0.45	0.36	0.38
Cash And Short Term Investments	-0.28	-0.47	-0.23	-0.29	-0.17	-0.29	-0.68	-0.16	-0.39	-0.23	0.27	-0.45	-0.25	-0.27	-0.19	-0.43	-0.28	0.36	0.28	1.0		0.33	-0.21	-0.45	0.36	0.38
Non Currrent Assets Other	-0.23	-0.32	-0.24	-0.21	-0.17	-0.23	-0.37	-0.15	-0.26	-0.27	-0.17	-0.32	-0.25	0.02	-0.28	-0.3	-0.04	-0.03	0.09	0.33	0.33		-0.19	-0.29	-0.09	-0.12
Accounts Payable	0.92	0.68	0.87	0.94	0.92	0.92	0.61	0.94	0.9	0.95	0.54	0.73	0.96	0.18	0.71	0.8	0.87	0.8	-0.32	-0.21	-0.21	-0.19		0.78	0.44	0.4
Intangible Assets	0.93	0.98	0.78	0.89	0.81	0.88	0.94	0.8	0.95	0.86	0.55	0.98	0.87	0.29	0.75	0.99	0.8	0.57	-0.04	-0.45	-0.45	-0.29	0.78		0.46	0.43
Common Stock Total Equity	0.52	0.4	0.5	0.52	0.52	0.5	0.23	0.48	0.46	0.58	0.97	0.41	0.48	0.16	0.68	0.45	0.34	0.7	0.23	0.36	0.36	-0.09	0.44	0.46		0.99
Common Stock	0.48	0.38	0.48	0.49	0.48	0.47	0.2	0.44	0.42	0.55	0.98	0.39	0.45	0.16	0.68	0.43	0.27	0.68	0.26	0.38	0.38	-0.12	0.4	0.43	0.99

Click cells to compare fundamentals

Balchem Account Relationship Matchups

Balchem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	1.2B	1.2B	1.6B	1.6B	1.7B
Short Long Term Debt Total	258.9M	176.4M	124.6M	440.6M	330.3M	346.9M
Other Current Liab	52.5M	68.3M	85.2M	72.4M	79.6M	83.6M
Total Current Liabilities	92.3M	94.4M	143.8M	140.0M	148.5M	155.9M
Total Stockholder Equity	743.7M	828.2M	877.0M	938.3M	1.1B	1.1B
Property Plant And Equipment Net	224.2M	236.5M	246.8M	290.8M	295.9M	310.7M
Net Debt	182.9M	79.0M	5.3M	374.0M	265.9M	279.2M
Retained Earnings	590.9M	656.7M	732.1M	814.5M	897.5M	942.4M
Non Current Assets Total	900.7M	899.0M	877.1M	1.3B	1.3B	1.3B
Net Receivables	93.4M	98.2M	117.4M	131.6M	125.3M	131.5M
Common Stock Shares Outstanding	32.5M	32.5M	32.7M	32.4M	32.4M	30.0M
Liabilities And Stockholders Equity	1.2B	1.2B	1.2B	1.6B	1.6B	1.7B
Non Current Liabilities Total	319.8M	243.2M	178.5M	546.2M	394.7M	414.5M
Inventory	83.9M	70.6M	91.1M	119.7M	109.5M	115.0M
Other Current Assets	11.9M	13.5M	10.5M	18.0M	15.0M	15.7M
Other Stockholder Equity	156.1M	165.2M	147.7M	128.8M	145.7M	152.9M
Total Liab	412.0M	337.6M	322.3M	686.2M	543.2M	570.4M
Property Plant And Equipment Gross	224.2M	236.5M	246.8M	290.8M	508.7M	534.1M
Total Current Assets	254.9M	266.9M	322.2M	335.8M	314.2M	330.0M
Accumulated Other Comprehensive Income	(5.6M)	4.2M	(5.0M)	(7.2M)	8.7M	9.1M
Cash	65.7M	84.6M	103.2M	66.6M	64.4M	46.2M
Cash And Short Term Investments	65.7M	84.6M	103.2M	66.6M	64.4M	46.2M
Non Currrent Assets Other	8.6M	11.3M	11.7M	(52.0M)	12.9M	13.5M
Accounts Payable	37.3M	23.7M	56.2M	57.3M	55.5M	58.3M
Intangible Assets	143.9M	121.7M	94.7M	213.3M	191.2M	200.8M
Common Stock Total Equity	2.2M	2.2M	2.2M	2.1M	2.5M	1.6M
Common Stock	2.2M	2.2M	2.2M	2.1M	2.2M	1.6M
Other Liab	64.6M	68.0M	69.9M	89.6M	103.0M	108.2M
Property Plant Equipment	216.9M	228.1M	246.8M	271.4M	312.1M	327.7M
Long Term Debt	256.4M	174.1M	108.6M	440.6M	309.6M	325.0M
Good Will	524.0M	529.5M	523.9M	769.5M	778.9M	817.9M
Other Assets	4.1M	19.7M	11.7M	10.8M	12.4M	13.1M
Net Tangible Assets	75.7M	298.8M	258.4M	168.8M	194.1M	129.0M
Retained Earnings Total Equity	590.9M	656.7M	732.1M	814.5M	936.7M	469.1M
Long Term Debt Total	163.4M	256.4M	174.1M	122.3M	140.6M	173.3M
Capital Surpluse	174.2M	173.0M	147.7M	128.8M	148.1M	135.9M
Deferred Long Term Liab	58.5M	51.4M	46.5M	62.8M	72.2M	43.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:

How To Invest In Balchem

Details

Is Balchem Stock a good investment?

Details

What is Balchem's Net Worth?

Details

Largest Specialty Chemicals Companies

View

Largest Basic Materials Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.144

Dividend Share

0.79

Earnings Share

3.72

Revenue Per Share

29.208

Quarterly Revenue Growth

0.043

The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Balchem Cost Of Revenue vs Ebit Per Revenue Analysis

Cost Of Revenue vs Ebit Per Revenue

Cost Of Revenue vs Ebit Per Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Ebit Per Revenue

Balchem fundamental ratios Correlations

Balchem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Balchem fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Non Current Liabilities Total

Cash And Short Term Investments	- 0.68	Net Debt
Cash	- 0.68	Net Debt
Cash And Short Term Investments	- 0.47	Short Long Term Debt Total
Cash	- 0.47	Short Long Term Debt Total
Intangible Assets	- 0.45	Cash And Short Term Investments
Intangible Assets	- 0.45	Cash